The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™

Cybin Inc. (NYSE American: CYBN) (NEO: CYBN)

Disseminated on behalf of Cybin Inc., may include paid advertisements. Investment Considerations Cybin Inc. currently has three molecules in development with four sponsored clinical trials planned for 2022 and a preclinical pipeline of 50+ novel assets. The company’s management team is composed of leaders with experience in various aspects of the pharmaceutical and innovative therapeutics … Continue reading “Cybin Inc. (NYSE American: CYBN) (NEO: CYBN)”

View Profile